CIP
NTUS

Convergence Investment Partners’s Natus Medical Inc NTUS Stock Holding History

Convergence Investment Partners’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,946
Closed -$221K – 330
2019
Q3 		$221K Sell
6,946
-2,694
-28% -$78.5K 0.06% 205
2019
Q2 		$248K Buy
+9,640
New +$246K 0.06% 220

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Convergence Investment Partners's NTUS Position: Q4 2019 in Review

Convergence Investment Partners sold out of Natus Medical Inc (NTUS) in Q4 2019, closing a stake of 6,946 shares — an estimated $221K sold.

Convergence Investment Partners first reported a position in NTUS in Q2 2019 and held it in 2 quarters. The position peaked at $248K in Q2 2019. 172 funds tracked by Wall St. Rank hold NTUS as of Q4 2019.

  • Convergence Investment Partners reported no remaining Natus Medical Inc position as of Q4 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 6,946 Natus Medical Inc shares in Q4 2019, an estimated $221K.
  • Convergence Investment Partners first reported a position in Natus Medical Inc in Q2 2019 and held it in 2 quarters.
  • Convergence Investment Partners's Natus Medical Inc position peaked at $248K in Q2 2019.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2019.

Based on Convergence Investment Partners's 13F filing for Q4 2019, filed 22 Jan 2020.